| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.4M | -76.4% | -4.8% |
| Gross Profit | $766K | — | -10.7% |
| R&D Expense | $3.5M | — | — |
| SG&A Expense | $2.8M | — | +186.0% |
| Operating Income | -$5.6M | — | — |
| Pre-tax Income | -$5.4M | — | -3182.4% |
| Income Tax | $0 | — | -100.0% |
| Net Income | -$5.4M | — | — |
| EPS (Basic) | -$0.09 | — | — |
| EPS (Diluted) | -$0.09 | — | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $593K | +35.1% | — |
| Current Assets | $24.1M | -16.5% | — |
| Total Assets | $24.8M | -16.4% | — |
| Current Liabilities | $2.3M | +1.0% | +1282.3% |
| Total Liabilities | $2.4M | -0.5% | +1358.4% |
| Stockholders' Equity | $22.4M | -17.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.2M | — | — |
| Capital Expenditures | $17K | — | -45.2% |
| Investing Cash Flow | -$17K | — | +45.2% |
| Financing Cash Flow | $3K | — | -95.7% |
| Free Cash Flow | -$5.3M | — | — |
| — |